Mouse IP-10 gene delivered by folate-modified chitosan nanoparticles and dendritic/tumour cells fusion vaccine effectively inhibit the growth of hepato-cellular carcinoma in mice: a future thermal study
Închide
Articolul precedent
Articolul urmator
806 1
Ultima descărcare din IBN:
2021-04-24 19:57
SM ISO690:2012
CHEN, Jiaojiao, HU, Zixi, ZHOU, Sufang, YANG, Nuo, DUAN, Siliang, ZHANG, Zhenghua, SU, Jing, HE, Jian, ZHANG, Zhiyong, LU, Xiaoling, ZHAO, Yongxiang. Mouse IP-10 gene delivered by folate-modified chitosan nanoparticles and dendritic/tumour cells fusion vaccine effectively inhibit the growth of hepato-cellular carcinoma in mice: a future thermal study. In: Central and Eastern European Conference on Thermal Analysis and Calorimetry, Ed. 4, 28-31 august 2017, Chişinău. Germany: Academica Greifswald, 2017, Editia 4, p. 497. ISBN 978-3-940237-47-7.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Central and Eastern European Conference on Thermal Analysis and Calorimetry
Editia 4, 2017
Conferința "Central and Eastern European Conference"
4, Chişinău, Moldova, 28-31 august 2017

Mouse IP-10 gene delivered by folate-modified chitosan nanoparticles and dendritic/tumour cells fusion vaccine effectively inhibit the growth of hepato-cellular carcinoma in mice: a future thermal study


Pag. 497-497

Chen Jiaojiao1, Hu Zixi1, Zhou Sufang1, Yang Nuo1, Duan Siliang1, Zhang Zhenghua1, Su Jing1, He Jian1, Zhang Zhiyong12, Lu Xiaoling1, Zhao Yongxiang1
 
1 Guangxi Medical University,
2 Rutgers, The State University of New Jersey
 
 
Disponibil în IBN: 31 octombrie 2019


Rezumat

Dendritic cells (DC) and tumour cell fusion vaccine (DC/tumour cell fusion vaccine) is considered an effective approach in cancer biotherapy. However, its therapeutic effects in early clinical trials have been suboptimal partially due to the immunosuppressive tumour environment. In this study, we used nanoparticles of folate (FA)-modified chitosan, a non-viral vector capable of targeting tumour cells with high expression of FA receptors. FA-chitosan nanoparticles were used as biological carriers for the expression plasmid of the mouse interferon-induced protein-10 (mIP10) gene, a potent chemoattractant for cytotoxic T cells. The combination of FA-chitosan/mIP-10 and DC/tumour cell fusion vaccine against hepatocellular carcinoma (HCC) effectively inhibited the growth of implanted HCC tumours and prolonged the survival of mice. The combination therapy significantly reduced myeloid-derived suppressor cells (MDSC) in mouse spleen, local tumour, and bone marrow while increasing tumour-specific IFN-γ responses. Furthermore, the combination therapy significantly inhibited tumor cell proliferation while promoting their apoptosis. Taken together, our data illustrate that the mIP-10 enhances the anti-tumour effect of DC/tumour cell fusion vaccine by alleviating the immunosuppressive tumour environment. In our future studies we aim to use the following thermal techniques: Thermal biosensor (calorimetric biosensor), which is a device using temperature sensitive element to measure the small temperature difference in biochemical reactions, the targets can be quantitatively based on the amount of heat produced by the biochemical reaction. The thermal biosensor is made up of two parts: one is a molecular recognition element for selective detection, and the other is a temperature conversion element that converts the heat produced during the reaction to the detectable signal. Photothermic therapy (PTT) is a therapeutic technique for killing tumour cells at high temperature by laser irradiation to produce heat energy. This technique also exhibits several other advantages such as simpler procedure, fewer complications, and short period in hospital. What’s more, it can kill cancer cells effectively without damage to healthy tissues.